Next Generation News and Research

RSS

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

The holidays should be a time when Americans focus on celebrating, reuniting with loved ones, enjoying holiday feasts and seemingly endless holiday treats. But, for the roughly 127 million Americans that struggle with maintaining healthy blood sugar and cholesterol levels, the stress of nearly two months of festivities can place enormous pressure on a body’s ability to maintain normal blood sugar and cholesterol levels.

11 Nov 2009

First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

Anthony Asher, MD, FACS, of Carolina Neurosurgery & Spine Associates in Charlotte, NC, has co-authored the first evidence-based, multidisciplinary treatment guidelines for brain metastases patients. These guidelines were recently presented at the Congress of Neurological Surgeons 2009 Annual Meeting in New Orleans, and were developed over the last year by a 20-member panel from various medical specialties.

11 Nov 2009

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

11 Nov 2009

First draft of the cassava genome complete

A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. The project is an important first step in accelerating the pace of research on this subsistence crop and addressing some of the many limitations that face cassava farmers around the world.

11 Nov 2009

Sanofi-aventis, Regeneron sign agreement to expand development collaboration

Sanofi-aventis and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.

11 Nov 2009

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

Onyx Pharmaceuticals, Inc. today announced nearly 20 presentations evaluating carfilzomib and ONX 0803 (SB 1518) in hematological cancers at the 51st American Society of Hematology (ASH) Annual Meeting December 5-8, 2009 in New Orleans, LA. Among the data presentations are four oral and seven poster presentations highlighting data from the carfilzomib development program in patients with relapsed and refractory multiple myeloma.

11 Nov 2009

IntriCon to launch new CDM device at 2009 AHA Scientific Sessions

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, announced today that it will unveil a prototype of its new Cardiac Diagnostic Monitoring (CDM) device, called the Mobile Patient ECG Telemetry System, or MPETS, at the 2009 American Heart Association (AHA) Scientific Sessions, Nov. 15-17, in Orlando, Fla.

11 Nov 2009

GORE TAG Thoracic Endoprosthesis receives European CE Mark approval

W.L. Gore & Associates (Gore) today announced that it has received European CE Mark approval for the next generation GORE TAG® Thoracic Endoprosthesis. The device is available in an expanded portfolio of sizes to meet a broad range of patient needs and was engineered to treat multiple etiologies including thoracic aortic aneurysms (TAAs), traumatic aortic transections and thoracic aortic dissections.

11 Nov 2009

SMI Manufacturing to invest $10 million in HealthSport

HealthSport, Inc., the preeminent formulator and developer of edible, multi-layer film strips that deliver drug and dietary supplement actives through buccal and sublingual absorption as well as oral ingestion, announced today that its strategic manufacturing partner, SMI Manufacturing, has agreed to invest $10 million into HealthSport.

11 Nov 2009

Life Technologies to acquire BioTrove

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.

10 Nov 2009

New multi-array technology package to diagnose complex food allergies

Today at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology, Phadia US introduced two new products designed specifically to meet the unique needs of the nation’s 6,000 allergists.

10 Nov 2009

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has acquired a portfolio of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called MDT-637.

10 Nov 2009

UC San Diego to launch new multidisciplinary program on health and migration

The University of California, San Diego will lead a new Center of Expertise on Migration and Health as one of three multi-campus initiatives launched by the University of California system under the auspices of the new UC Global Health Institute.

10 Nov 2009

ZeOmega announces alliance with Eldorado Computing to offer integrated care management solution

ZeOmega, a premier provider of care management software solutions and services, today announced its strategic alliance with Eldorado Computing Inc. (ELDORADO), an MphasiS Company and a leading provider of health benefit and claims management platforms, to offer an integrated care and benefits management solution.

9 Nov 2009

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

Varian, Inc. announced today the release of the 325-MS triple-quadrupole LC/MS (liquid chromatograph/mass spectrometer) for the efficient detection and identification of chemical compounds in high-throughput laboratories performing environmental, food safety, and toxicology analyses.

6 Nov 2009

Elysium Internet launches two new online destinations

Elysium Internet, Inc., a next generation Local Internet advertising and digital media Company, today announced the launch of two new online destinations www.PodiatristSites.com and www.LocalPhysician.com as the company seeks to expand its portfolio of health related online destinations.

6 Nov 2009

SpineSmith Partners signs product development agreement with GenOsteo

SpineSmith Partners has signed an initial agreement with GenOsteo, Inc. to co-develop a unique scaffold that mimics the structure of natural cancellous bone.

5 Nov 2009

Arrayit joins federal government to help control health care costs through early diagnosis of diseases

Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs through early diagnosis of diseases.

5 Nov 2009

King Pharmaceuticals announces total revenues of $463M for the third quarter of 2009

King Pharmaceuticals, Inc. announced today that total revenues were $463 million during the third quarter ended September 30, 2009, compared to $388 million in the third quarter of 2008. The Company reported net income of $42 million and diluted earnings per share of $0.17 during the third quarter of 2009, compared to net income of $82 million and diluted earnings per share of $0.34 in the third quarter of the prior year.

5 Nov 2009

Columbia Laboratories reports net revenues of $7.9 million for third quarter 2009

Columbia Laboratories, Inc. today reported financial results for the three- and nine-month periods ended September 30, 2009.

5 Nov 2009

Next Generation News and Research

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

Cambridge based hub to use DNA sequencing platforms for advancing its targeted medical resequencing studies

First draft of the cassava genome complete

Sanofi-aventis, Regeneron sign agreement to expand development collaboration

Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting

IntriCon to launch new CDM device at 2009 AHA Scientific Sessions

GORE TAG Thoracic Endoprosthesis receives European CE Mark approval

SMI Manufacturing to invest $10 million in HealthSport

Life Technologies to acquire BioTrove

New multi-array technology package to diagnose complex food allergies

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

UC San Diego to launch new multidisciplinary program on health and migration

ZeOmega announces alliance with Eldorado Computing to offer integrated care management solution

Varian launches its 325-MS triple-quadrupole liquid chromatograph/mass spectrometer

Elysium Internet launches two new online destinations

SpineSmith Partners signs product development agreement with GenOsteo

Arrayit joins federal government to help control health care costs through early diagnosis of diseases

King Pharmaceuticals announces total revenues of $463M for the third quarter of 2009

Columbia Laboratories reports net revenues of $7.9 million for third quarter 2009

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News